These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 12162803

  • 1. Variable FEV1 following methacholine inhalation.
    Haynes JM.
    Respir Care; 2002 Aug; 47(8):915-7. PubMed ID: 12162803
    [No Abstract] [Full Text] [Related]

  • 2. Deep inhalation bronchoprotection.
    Cockcroft DW, Davis BE.
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):74-5. PubMed ID: 22727163
    [No Abstract] [Full Text] [Related]

  • 3. Value of the peak expiratory flow in bronchodynamic tests.
    Pino JM, García-Río F, Prados C, Alvarez-Sala R, Díaz S, Villasante C, Villamor J.
    Allergol Immunopathol (Madr); 1996 Jul; 24(2):54-7. PubMed ID: 8933890
    [Abstract] [Full Text] [Related]

  • 4. The potential use of spirometry during methacholine challenge test in young children with respiratory symptoms.
    Vilozni D, Livnat G, Dabbah H, Elias N, Hakim F, Bentur L.
    Pediatr Pulmonol; 2009 Jul; 44(7):720-7. PubMed ID: 19499592
    [Abstract] [Full Text] [Related]

  • 5. Conflicting methacholine challenge tests.
    Haynes JM.
    Respir Care; 2006 Jan; 51(1):62-6. PubMed ID: 16381620
    [No Abstract] [Full Text] [Related]

  • 6. Sensitivity of FEV1 and indices of flow volume curve in the methacholine test.
    Mannino F, Mariotta S, Anticoli S, Lambert-Gardini S, Terzano C.
    Allergol Immunopathol (Madr); 1996 Jan; 24(2):75-80. PubMed ID: 8933893
    [Abstract] [Full Text] [Related]

  • 7. Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm.
    Kacmarek RM, Ripple R, Cockrill BA, Bloch KJ, Zapol WM, Johnson DC.
    Am J Respir Crit Care Med; 1996 Jan; 153(1):128-35. PubMed ID: 8542105
    [Abstract] [Full Text] [Related]

  • 8. Duration of bronchoprotection of inhaled ipratropium against inhaled methacholine.
    Illamperuma C, Davis BE, Fenton ME, Cockcroft DW.
    Ann Allergy Asthma Immunol; 2009 May; 102(5):438-9. PubMed ID: 19496252
    [No Abstract] [Full Text] [Related]

  • 9. Methacholine dry powder inhaler as a new tool for bronchial challenge test.
    Colombo G, Terzano C, Colombo P, Petroianni A, Ricci A, Buttini F.
    Int J Pharm; 2008 Mar 20; 352(1-2):165-71. PubMed ID: 18055141
    [Abstract] [Full Text] [Related]

  • 10. Reduced vital capacity after methacholine challenge in early childhood--is it due to trapped air or loss of motivation.
    Vilozni D, Hakim F, Adler A, Livnat G, Bar-Yishay E, Bentur L.
    Respir Med; 2009 Jan 20; 103(1):109-16. PubMed ID: 18804359
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of sensitivity and specifity of two bronchial provocation tests with methacholine and hypertonic saline in bronchial hyperreactivity evaluation in asthmatics].
    Piotrowska T, Siergiejko G, Siergiejko Z.
    Pol Merkur Lekarski; 2007 Feb 20; 22(128):126-9. PubMed ID: 17598657
    [Abstract] [Full Text] [Related]

  • 12. Ipratropium bromide in the recovery phase after methacholine PD20: is there more than an antagonist effect?
    Mannino F, Terzano C.
    Allergol Immunopathol (Madr); 1998 Feb 20; 26(6):273-6. PubMed ID: 9934405
    [Abstract] [Full Text] [Related]

  • 13. Limitations of objective measures of asthma.
    Bellamkonda P, Warrier P, Stokes JR, Chiang DT, Clark JP, Romero FA, Casale TB.
    Ann Allergy Asthma Immunol; 2009 Jun 20; 102(6):530-1. PubMed ID: 19558014
    [No Abstract] [Full Text] [Related]

  • 14. Methacholine challenge test as an adjunctive investigative tool in patients with asthma-like symptoms: the Sabah experience.
    Tie ST, Wong JL, Beniyamin A, Ho A, Kannan SK, Jamalul Azizi AR.
    Med J Malaysia; 2012 Apr 20; 67(2):204-6. PubMed ID: 22822644
    [Abstract] [Full Text] [Related]

  • 15. Utility and limitations of objective measures of asthma.
    Warrier PJ, Bellamkonda P, Stokes JR, Casale TB.
    Ann Allergy Asthma Immunol; 2009 Jun 20; 102(6):518-22. PubMed ID: 19558012
    [No Abstract] [Full Text] [Related]

  • 16. Dosimeter methacholine challenge: comparison of maximal versus submaximal inhalations.
    Todd DC, Davis BE, Hurst TS, Cockcroft DW.
    J Allergy Clin Immunol; 2004 Sep 20; 114(3):517-9. PubMed ID: 15356550
    [Abstract] [Full Text] [Related]

  • 17. Recovery time following bronchial challenge.
    Currie GP, Paterson E, Anderson WJ, Lee DK.
    Respir Med; 2005 May 20; 99(5):653. PubMed ID: 15823466
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of the methacholine PC15.
    Peters GE, Davis BE, Cockcroft DW.
    Ann Allergy Asthma Immunol; 2011 Oct 20; 107(4):371. PubMed ID: 21962099
    [No Abstract] [Full Text] [Related]

  • 19. Response to mannitol in asymptomatic subjects with airway hyper-responsiveness to methacholine.
    Porsbjerg C, Rasmussen L, Thomsen SF, Brannan JD, Anderson SD, Backer V.
    Clin Exp Allergy; 2007 Jan 20; 37(1):22-8. PubMed ID: 17210038
    [Abstract] [Full Text] [Related]

  • 20. Standardization of methacholine inhalation challenge.
    Sekerel BE, Saraçlar Y, Tuncer A, Adalioğlu G, Cetinkaya F.
    Turk J Pediatr; 1997 Jan 20; 39(2):165-72. PubMed ID: 9223913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.